Skip to Content
Merck

Enhanced human receptor binding by H5 haemagglutinins.

Virology (2014-06-04)
Xiaoli Xiong, Haixia Xiao, Stephen R Martin, Peter J Coombs, Junfeng Liu, Patrick J Collins, Sebastien G Vachieri, Philip A Walker, Yi Pu Lin, John W McCauley, Steven J Gamblin, John J Skehel
ABSTRACT

Mutant H5N1 influenza viruses have been isolated from humans that have increased human receptor avidity. We have compared the receptor binding properties of these mutants with those of wild-type viruses, and determined the structures of their haemagglutinins in complex with receptor analogues. Mutants from Vietnam bind tighter to human receptor by acquiring basic residues near the receptor binding site. They bind more weakly to avian receptor because they lack specific interactions between Asn-186 and Gln-226. In contrast, a double mutant, Δ133/Ile155Thr, isolated in Egypt has greater avidity for human receptor while retaining wild-type avidity for avian receptor. Despite these increases in human receptor binding, none of the mutants prefers human receptor, unlike aerosol transmissible H5N1 viruses. Nevertheless, mutants with high avidity for both human and avian receptors may be intermediates in the evolution of H5N1 viruses that could infect both humans and poultry.

MATERIALS
Product Number
Brand
Product Description

USP
Zanamivir, United States Pharmacopeia (USP) Reference Standard
SKU
Pack Size
Availability
Price
Quantity
Sigma-Aldrich
Zanamivir, ≥98% (HPLC)
SKU
Pack Size
Availability
Price
Quantity